Hemp Enforcement, Modernization, and Protection Act

Product Safety and Transparency: The bill establishes strict standards for what makes a product "adulterated" or "misbranded," which helps ensure products are not contaminated or falsely advertised (Section 1002, Section 1003).

Consumer Information: Labeling requirements ensure that consumers receive accurate information regarding ingredients, serving sizes, and potential risks to special populations like children or pregnant individuals (Section 1003).

Safety for Inhalable Products: By requiring certain inhalable products to be sold in prefilled, nonrefillable cartridges, the bill regulates how these products are delivered to the respiratory tract (Section 1005).

Protection of Vulnerable Groups: The bill prohibits the sale of cannabinoid hemp products to anyone under 21 years of age (Section 1007) and requires warnings for special populations (Section 1003).

Rapid Response to Risks: The Secretary is granted mandatory recall authority to act if a product is likely to cause serious adverse health consequences or death (Section 1011).

Strict Manufacturing Burdens: The bill requires facilities to register with the Secretary and submit detailed product listings, which creates new regulatory requirements for businesses (Section 1009, Section s 1009(b)).

Increased Industry Requirements: Inhalable products must undergo a pre-market notification process, requiring the reporting of formulations and labeling to the Secretary (Section 1005(i)).

Strict Limitations on Products: Certain products, such as those intended for food-producing animals or those containing specific synthetic cannabinoids, are classified as "prohibited" (Section 201(xx)).

Potential for Criminal Penalties: The act introduces enhanced criminal penalties, including potential imprisonment for up to 10 years for those who knowingly violate certain provisions (Section 5(b)).